(Q82691002)
Statements
A retrospective study to determine if hydroxyurea augmentation of antiretroviral drug regimens that contain ddI and/or d4T increases the risk of developing peripheral neuropathy in HIV-1 infected individuals (English)
W F McCarthy
J Gable
J Lawrence
M Thompson
AIDS Research Consortium of Atlanta ASD Investigators
1 January 2000